A pharma company that produces mifepristone asked the Supreme Court to lift a lower court's ruling barring health providers from dispensing the abortion pill by mail.
The Fifth Circuit Court's ruling, which is being appealed, reinstates a requirement that patients visit a health care provider in person to obtain mifepristone, upending abortion access in the United States.
